BAX and melanoma: Thymoquinone has shown effective results in treating melanoma (MDA-MB-435) by activating the intrinsic apoptosis pathway, while suppressing Akt phosphorylation, and increasing the Bax/Bcl-2 ratio (Fig. 2).